StonvexLoading…
StonvexStonvexStonvexCore line items from HLNE's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-03-31 | Annual 2024 2024-03-31 | Annual 2023 2023-03-31 | Annual 2022 2022-03-31 |
|---|---|---|---|---|
Revenue | $712.96M | $553.84M | $528.75M | $367.92M |
Operating Income | $362.28M | $281.66M | $242.61M | $313.68M |
Net Income | $217.42M | $140.86M | $109.12M | $145.99M |
EPS (Diluted) | Not available | Not available | Not available | $3.98 |
Total Assets | $1.69B | $1.27B | $1.14B | $1.29B |
Total Liabilities | $766.46M | $595.24M | $566.35M | $557.46M |
Cash & Equivalents | $283.60M | $119.62M | $116.55M | $76.20M |
Free Cash Flow OCF − CapEx | $288.66M | $109.78M | $221.84M | $161.00M |
Shares Outstanding | Not available | Not available | Not available | Not available |